We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
These 3 Stocks Soared Following Strong Quarterly Results
Key Takeaways
Several companies have seen their shares benefit from better-than-expected results.
META, MSFT, and BSX have all enjoyed positivity post-earnings.
The reporting docket remains stacked, with many surprises still to come.
The 2025 Q1 earnings cycle is in full swing, with many companies on the docket to reveal quarterly results in the coming weeks.
Guidance is a key factor in this cycle, more so than we’ve seen in recent periods due to the overall level of uncertainty brought about by recent tariff announcements and other economic developments.
So far, several companies, including Boston Scientific (BSX - Free Report) , Meta Platforms (META - Free Report) , and Microsoft (MSFT - Free Report) , have all delivered positive results, with each seeing a bullish share reaction post-earnings. Let’s take a closer look at the positivity.
BSX Raises Guidance
Boston Scientific exceeded both top and bottom line expectations handily, delivering a strong 12% EPS beat alongside sales that were 2.3% ahead of expectations. Upgraded current-year guidance has provided a notably bullish outlook, with the stock also now sporting a coveted Zacks Rank #2 (Buy).
Analysts have adjusted their current year sales and EPS expectations accordingly following the favorable print, with BSX expected to see 16% EPS growth on 17% higher sales. The stock sports a Style Score of ‘B’ for Value.
Below is the current fiscal year EPS revisions trend.
Image Source: Zacks Investment Research
Below is the current fiscal year sales revisions trend.
Image Source: Zacks Investment Research
Strong segment performance has aided the company’s bright outlook, leading to the above-mentioned guidance upgrade in an overall uncertain environment.
Meta Ad Revenue Remains Robust
Meta Platforms continued to fire on all cylinders throughout its latest period, again exceeding our consensus EPS and sales expectations handily and posting strong growth. Sales grew an impressive 16% year-over-year thanks to strong Advertising results, which totaled a solid $41.3 billion.
Below is a chart illustrating META’s Ad revenue on a quarterly basis.
Image Source: Zacks Investment Research
Notably, the company’s average price per ad climbed 10% year-over-year, with its family daily active people (DAP) also seeing a 6% move higher year-over-year. The company’s user base growth has continued to be outstanding, providing many clear benefits.
Microsoft Cloud Impresses
Concerning headline figures in Microsoft’s release, EPS of $3.46 and sales of $70.0 billion both handily exceeded our consensus expectations, continuing its recent streak of better-than-expected results. Sales grew an impressive 13% year-over-year, whereas EPS climbed 18%.
Unsurprisingly, Microsoft Cloud and AI strength drove the strong results, with Microsoft Cloud revenue soaring 20% year-over-year to $42.4 billion. Demand has remained strong for the tech titan, with commentary alluding to the trend remaining for years to come.
Importantly, its Intelligent Cloud (includes Azure) revenue totaled a strong $26.8 billion, up 21% from the year-ago period. The Intelligent Cloud results snapped a small streak of misses on the metric, as shown below.
Image Source: Zacks Investment Research
Bottom Line
The 2025 Q1 cycle continues to roll along, with all three stocks above – Boston Scientific (BSX - Free Report) , Meta Platforms (META - Free Report) , and Microsoft (MSFT - Free Report) – seeing a nice move higher following their respective quarterly releases.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
These 3 Stocks Soared Following Strong Quarterly Results
Key Takeaways
The 2025 Q1 earnings cycle is in full swing, with many companies on the docket to reveal quarterly results in the coming weeks.
Guidance is a key factor in this cycle, more so than we’ve seen in recent periods due to the overall level of uncertainty brought about by recent tariff announcements and other economic developments.
So far, several companies, including Boston Scientific (BSX - Free Report) , Meta Platforms (META - Free Report) , and Microsoft (MSFT - Free Report) , have all delivered positive results, with each seeing a bullish share reaction post-earnings. Let’s take a closer look at the positivity.
BSX Raises Guidance
Boston Scientific exceeded both top and bottom line expectations handily, delivering a strong 12% EPS beat alongside sales that were 2.3% ahead of expectations. Upgraded current-year guidance has provided a notably bullish outlook, with the stock also now sporting a coveted Zacks Rank #2 (Buy).
Analysts have adjusted their current year sales and EPS expectations accordingly following the favorable print, with BSX expected to see 16% EPS growth on 17% higher sales. The stock sports a Style Score of ‘B’ for Value.
Below is the current fiscal year EPS revisions trend.
Image Source: Zacks Investment Research
Below is the current fiscal year sales revisions trend.
Image Source: Zacks Investment Research
Strong segment performance has aided the company’s bright outlook, leading to the above-mentioned guidance upgrade in an overall uncertain environment.
Meta Ad Revenue Remains Robust
Meta Platforms continued to fire on all cylinders throughout its latest period, again exceeding our consensus EPS and sales expectations handily and posting strong growth. Sales grew an impressive 16% year-over-year thanks to strong Advertising results, which totaled a solid $41.3 billion.
Below is a chart illustrating META’s Ad revenue on a quarterly basis.
Image Source: Zacks Investment Research
Notably, the company’s average price per ad climbed 10% year-over-year, with its family daily active people (DAP) also seeing a 6% move higher year-over-year. The company’s user base growth has continued to be outstanding, providing many clear benefits.
Microsoft Cloud Impresses
Concerning headline figures in Microsoft’s release, EPS of $3.46 and sales of $70.0 billion both handily exceeded our consensus expectations, continuing its recent streak of better-than-expected results. Sales grew an impressive 13% year-over-year, whereas EPS climbed 18%.
Unsurprisingly, Microsoft Cloud and AI strength drove the strong results, with Microsoft Cloud revenue soaring 20% year-over-year to $42.4 billion. Demand has remained strong for the tech titan, with commentary alluding to the trend remaining for years to come.
Importantly, its Intelligent Cloud (includes Azure) revenue totaled a strong $26.8 billion, up 21% from the year-ago period. The Intelligent Cloud results snapped a small streak of misses on the metric, as shown below.
Image Source: Zacks Investment Research
Bottom Line
The 2025 Q1 cycle continues to roll along, with all three stocks above – Boston Scientific (BSX - Free Report) , Meta Platforms (META - Free Report) , and Microsoft (MSFT - Free Report) – seeing a nice move higher following their respective quarterly releases.